THE EFFECT OF 5-HT1A RECEPTOR LIGANDS IN A CHRONIC MILD STRESS MODEL OF DEPRESSION

被引:59
作者
PRZEGALINSKI, E
MORYL, E
PAPP, M
机构
[1] Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow
关键词
DEPRESSION; ANIMAL MODEL; ANHEDONIA; IMIPRAMINE; CITALOPRAM; 8-OH-DPAT; IPSAPIRONE; BUSPIRONE; WAY; 100135; RAT;
D O I
10.1016/0028-3908(95)00102-C
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Antidepressant properties of 5-HT1A receptor ligands (the full agonist 8-OH-DPAT, the partial agonists ipsapirone and buspirone, and the selective antagonist WAY 100135) were studied in a chronic mild stress model of depression. In this model, rats subjected to a variety of mild stressors for a prolonged period of time show a substantial decrease in the consumption of a 1% sucrose solution (anhedonia), an effect being sensitive to repeated treatment with antidepressant drugs. In the present study we found that the stress-induced deficit in the sucrose intake was gradually reversed by chronic (3-5 weeks) administration of buspirone (2.5 and 5 mg/kg, i.p., b.i.d.) or WAY 100135 (10 mg/kg, s.c., b.i.d.), but not 8-OH-DPAT (0.5 mg/kg, s.c., b.i.d.) or ipsapirone (5 mg/kg i.p., b.i.d.). The magnitude of the effect of buspirone and WAY 100135 was comparable to that observed following similar administration of the antidepressant drugs imipramine (10 mg/kg i.p.) or citalopram (10 mg/kg i.p.). Increases in the sucrose intake following chronic treatment with buspirone, WAY 100135, imipramine and citalopram were specific to the stressed animals; the behaviour of control non-stressed animals was unchanged by any drug. These results suggest that buspirone and WAY 100135 may have antidepressant properties. Possible links between the anti-anhedonic effect of these drugs and their interaction with 5-HT1A receptors and/or the dopamine system are discussed.
引用
收藏
页码:1305 / 1310
页数:6
相关论文
共 44 条
[11]  
GARATTINI S, 1982, J CLIN PSYCHIAT, V43, P19
[12]   REVERSAL OF HELPLESS BEHAVIOR IN RATS BY PUTATIVE 5-HT1A AGONISTS [J].
GIRAL, P ;
MARTIN, P ;
SOUBRIE, P ;
SIMON, P .
BIOLOGICAL PSYCHIATRY, 1988, 23 (03) :237-242
[13]  
Glaser T., 1992, SEROTONIN 1A RECEPTO, P35
[14]   5-HT RECEPTORS - SUBTYPES AND 2ND MESSENGERS [J].
HOYER, D ;
SCHOEFFTER, P .
JOURNAL OF RECEPTOR RESEARCH, 1991, 11 (1-4) :197-214
[15]   PHARMACOLOGICAL CHARACTERIZATION OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) [J].
HYTTEL, J .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 :19-26
[16]  
Kahn R S, 1992, Eur Neuropsychopharmacol, V2, P1, DOI 10.1016/0924-977X(92)90031-3
[17]   ANTIDEPRESSANT-LIKE ACTION OF 5-HT1A AGONISTS AND CONVENTIONAL ANTIDEPRESSANTS IN AN ANIMAL-MODEL OF DEPRESSION [J].
KENNETT, GA ;
DOURISH, CT ;
CURZON, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 134 (03) :265-274
[18]   THE INVOLVEMENT OF SEROTONIN IN PSYCHIATRIC-DISORDERS AND BEHAVIOR [J].
LOPEZIBOR, JJ .
BRITISH JOURNAL OF PSYCHIATRY, 1988, 153 :26-39
[19]   ANTIDEPRESSANT-LIKE BEHAVIORAL-EFFECTS OF SEROTONIN RECEPTOR AGONISTS [J].
LUCKI, I ;
SINGH, A ;
KREISS, DS .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1994, 18 (01) :85-95
[20]  
MCMILLEN BA, 1983, J NEUROSCI, V3, P733